Mindbeam AI Research Leverages Generative AI to Develop Novel Pain Therapeutics with Improved Predicted Liver Safety

Summary

Mindbeam AI announced the identification of three TRPV1-targeting compounds using generative AI designed to reduce predicted liver toxicity for pain therapeutics. The research focuses on improving safety profiles for next-generation pain therapies.